Molecular alterations associated with breast cancer mortality.
about
Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor geneMosaic 13q14 deletions in peripheral leukocytes of non-hematologic cancer cases and healthy controlsOVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma.
P2860
Molecular alterations associated with breast cancer mortality.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Molecular alterations associated with breast cancer mortality.
@ast
Molecular alterations associated with breast cancer mortality.
@en
Molecular alterations associated with breast cancer mortality.
@nl
type
label
Molecular alterations associated with breast cancer mortality.
@ast
Molecular alterations associated with breast cancer mortality.
@en
Molecular alterations associated with breast cancer mortality.
@nl
prefLabel
Molecular alterations associated with breast cancer mortality.
@ast
Molecular alterations associated with breast cancer mortality.
@en
Molecular alterations associated with breast cancer mortality.
@nl
P2093
P2860
P1433
P1476
Molecular alterations associated with breast cancer mortality.
@en
P2093
Craig D Shriver
J Leigh Campbell
Kim Mamula
Laura M Voeghtly
Rachel E Ellsworth
P2860
P304
P356
10.1371/JOURNAL.PONE.0046814
P407
P577
2012-10-04T00:00:00Z